Literature DB >> 18955863

Altered bile acid metabolism in childhood functional constipation: inactivation of secretory bile acids by sulfation in a subset of patients.

Alan F Hofmann1, Vera Loening-Baucke, Joel E Lavine, Lee R Hagey, Joseph H Steinbach, Christine A Packard, Terrance L Griffin, Dale A Chatfield.   

Abstract

OBJECTIVE: An elevated concentration in the colon of the primary bile acid chenodeoxycholic acid (CDCA) or the secondary bile acid deoxycholic acid (DCA) is known to induce water secretion, causing diarrhea. We hypothesized that of the many fecal bile acids, only CDCA and DCA function as endogenous laxatives; therefore, a decrease in their proportion may be a cause of childhood functional constipation. To test this possibility, fecal bile acid composition was determined in children with functional constipation and in nonconstipated control children. PATIENTS AND METHODS: Fecal samples were obtained from 207 children, 103 with functional constipation and 104 with normal bowel habits. Bile acid classes were determined by use of electrospray ionization-single ion monitoring-mass spectrometry (ESI-SIM-MS), and individual bile acids were measured by gas chromatography (GC)-MS (GC-MS). The structure of individual sulfated bile acids was obtained by use of liquid chromatography (LC)-MS (LC-MS).
RESULTS: By ESI-SIM-MS, the proportions of DCA did not differ in constipated children (n = 73) from that in control children (n = 92), but monosulfated dihydroxy bile acids were greater (P < 0.05). The difference was attributable to 6 patients in the constipated group whose major fecal bile acid by LC-MS was the 3-sulfate of CDCA. Sulfation of CDCA is known to abolish its secretory activity. By GC-MS, the bile acid profile was identical in the 2 groups.
CONCLUSIONS: In most children with functional constipation, the fecal bile acid profile seems to be normal. There is a small subset of children, however, whose dominant fecal bile acid is the 3-sulfate of CDCA, indicating a novel disturbance in bile acid metabolism. Such sulfation abolishes the secretory activity of CDCA and may contribute to constipation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18955863     DOI: 10.1097/MPG.0b013e31816920a6

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  26 in total

1.  Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea.

Authors:  Banny S Wong; Michael Camilleri; Paula Carlson; Sanna McKinzie; Irene Busciglio; Olga Bondar; Roy B Dyer; Jesse Lamsam; Alan R Zinsmeister
Journal:  Clin Gastroenterol Hepatol       Date:  2012-05-18       Impact factor: 11.382

2.  Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function.

Authors:  Suwebatu T Odunsi-Shiyanbade; Michael Camilleri; Sanna McKinzie; Duane Burton; Paula Carlson; Irene A Busciglio; Jesse Lamsam; Ravinder Singh; Alan R Zinsmeister
Journal:  Clin Gastroenterol Hepatol       Date:  2009-10-30       Impact factor: 11.382

3.  Bile Acid Deficiency in a Subgroup of Patients With Irritable Bowel Syndrome With Constipation Based on Biomarkers in Serum and Fecal Samples.

Authors:  Priya Vijayvargiya; Irene Busciglio; Duane Burton; Leslie Donato; Alan Lueke; Michael Camilleri
Journal:  Clin Gastroenterol Hepatol       Date:  2017-06-27       Impact factor: 11.382

Review 4.  Bile acids: analysis in biological fluids and tissues.

Authors:  William J Griffiths; Jan Sjövall
Journal:  J Lipid Res       Date:  2010-01       Impact factor: 5.922

Review 5.  Microbial biotransformations of bile acids as detected by electrospray mass spectrometry.

Authors:  Lee R Hagey; Matthew D Krasowski
Journal:  Adv Nutr       Date:  2013-01-01       Impact factor: 8.701

Review 6.  Bile salts of vertebrates: structural variation and possible evolutionary significance.

Authors:  Alan F Hofmann; Lee R Hagey; Matthew D Krasowski
Journal:  J Lipid Res       Date:  2009-07-28       Impact factor: 5.922

7.  Development of a bile acid-based newborn screen for Niemann-Pick disease type C.

Authors:  Xuntian Jiang; Rohini Sidhu; Laurel Mydock-McGrane; Fong-Fu Hsu; Douglas F Covey; David E Scherrer; Brian Earley; Sarah E Gale; Nicole Y Farhat; Forbes D Porter; Dennis J Dietzen; Joseph J Orsini; Elizabeth Berry-Kravis; Xiaokui Zhang; Janice Reunert; Thorsten Marquardt; Heiko Runz; Roberto Giugliani; Jean E Schaffer; Daniel S Ory
Journal:  Sci Transl Med       Date:  2016-05-04       Impact factor: 17.956

8.  Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome.

Authors:  Andrea Shin; Michael Camilleri; Priya Vijayvargiya; Irene Busciglio; Duane Burton; Michael Ryks; Deborah Rhoten; Alan Lueke; Amy Saenger; Adam Girtman; Alan R Zinsmeister
Journal:  Clin Gastroenterol Hepatol       Date:  2013-04-30       Impact factor: 11.382

9.  A simple and accurate HPLC method for fecal bile acid profile in healthy and cirrhotic subjects: validation by GC-MS and LC-MS.

Authors:  Genta Kakiyama; Akina Muto; Hajime Takei; Hiroshi Nittono; Tsuyoshi Murai; Takao Kurosawa; Alan F Hofmann; William M Pandak; Jasmohan S Bajaj
Journal:  J Lipid Res       Date:  2014-03-13       Impact factor: 5.922

10.  Methods for diagnosis of bile acid malabsorption in clinical practice.

Authors:  Priya Vijayvargiya; Michael Camilleri; Andrea Shin; Amy Saenger
Journal:  Clin Gastroenterol Hepatol       Date:  2013-05-02       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.